MTOR and ovarian cancer: They suppressed LRP6 expression, inhibited both Wnt/β-catenin and mTOR/STAT3 signaling in ovarian cancer ascites cells and chemoresistant cell lines, and displayed potent in vitro anti-proliferative effects.